ישראל - עברית - Ministry of Health

bristol-myers squibb (israel) limited - ixabepilone 45 mg - powder for concentrate for infusion - ixabepilone - ixempra is indicated for the treatment of inoperable locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy:in combination with capecitabine in patients failing prior therapy with a taxane and an anthracycline or for whom further anthracycline therapy is not indicated.as monotherapy in patients failing prior therapy with taxanes, capecitabine and anthracyclines or for whom further anthracycline therapy is not indicated.

ישראל - עברית - Ministry of Health

pharmalogic ltd - oxaliplatin 50 mg/vial - powder for concentrate for infusion - oxaliplatin - oxaliplatin in combination with 5- fluorouracil and folinic acid (fa) is indicated for : * adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour * treatment of advanced colorectal cancer.

ישראל - עברית - Ministry of Health

pharmalogic ltd - oxaliplatin 100 mg/vial - powder for concentrate for infusion - oxaliplatin - oxaliplatin in combination with 5- fluorouracil and folinic acid (fa) is indicated for : * adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour * treatment of advanced colorectal cancer.

ישראל - עברית - Ministry of Health

pharmalogic ltd - oxaliplatin 150 mg/vial - powder for concentrate for infusion - oxaliplatin - oxaliplatin in combination with 5- fluorouracil and folinic acid (fa) is indicated for : * adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour * treatment of advanced colorectal cancer.

ישראל - עברית - Ministry of Health

devries & co. ltd - topotecan hydrochloride 1 mg - powder for concentrate for soution for infusion - topotecan - treatment of metastatic carcinoma of the ovary after failure of initial or subsequent therapy. treatment of small cell lung cancer sensitive disease after failure of first line chemotherapy. topotecan in combination with cisplatin is indicated for the treatment of stage iv-b recurrent or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy.

ישראל - עברית - Ministry of Health

medison pharma ltd - topotecan hydrochloride 4 mg/vial - powder for concentrate for infusion - topotecan - treatment of metastatic carcinoma of the ovary after failure of initial or subsequent therapy.treatment of small cell lung cancer sensitive disease after failure of first line chemotherapy. topotecan in combination with cisplatin is indicated for the treatment of stage iv-b recurrent or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy.

ישראל - עברית - Ministry of Health

j-c health care ltd - infliximab 100 mg/vial - powder for concentrate for infusion - infliximab - - adult :crohn's disease: treatment of severe active crohn's disease in patients who have not responded despite of a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant. treatment of fistulising crohn's disease in patients who have not responded despite of a full and adequate course of therapy with conventional treatment. -paediatric crohn's disease: remicade is indicated for: treatment of severe active crohn's disease in paediatric patients aged 6 to 17 years who have not responded to conventional therapy including a corticosteroid an immunomodulator and primary nutrition therapy or who are intolerant to or have contraindications for such therapies. remicade has been studied only in combination with conventional immunosuppressive therapy -ankylosing spondylitis: remicade is indicated for: treatment of ankylosing spondylitis in patients who have severe axial symptoms elevated serological markers of inflammatory activity and who have responded inadequately to conventional ther

ישראל - עברית - Ministry of Health

bristol-myers squibb (israel) limited - belatacept 25 mg/ml - powder for concentrate for infusion - belatacept - nulojix, in combination with corticosteroids and mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adults receiving a renal transplant. it is recommended to add an interleukin (il)-2 receptor antagonist for induction therapy to this belatacept-based regimen

ישראל - עברית - Ministry of Health

פרמייר ים המלח מעבדות קוסמטיקס בעמ - שיפור מראה העור

ישראל - עברית - Ministry of Health

שולמית קוסמטיקה ואירוסול (1999) בעמ - טיפוח עור הגוף